Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 1
1986 4
1987 2
1988 2
1989 3
1990 4
1991 1
1992 2
1993 3
1994 4
1995 9
1996 11
1998 5
1999 2
2000 8
2001 11
2002 8
2003 8
2004 15
2005 14
2006 22
2007 20
2008 26
2009 33
2010 29
2011 53
2012 55
2013 62
2014 62
2015 74
2016 96
2017 108
2018 101
2019 134
2020 135
2021 157
2022 236
2023 188
2024 94

Text availability

Article attribute

Article type

Publication date

Search Results

1,607 results

Results by year

Filters applied: . Clear all
Page 1
Mesenchymal stem cells and their microenvironment.
Liu J, Gao J, Liang Z, Gao C, Niu Q, Wu F, Zhang L. Liu J, et al. Among authors: niu q. Stem Cell Res Ther. 2022 Aug 20;13(1):429. doi: 10.1186/s13287-022-02985-y. Stem Cell Res Ther. 2022. PMID: 35987711 Free PMC article. Review.
Systematic discovery of mutation-directed neo-protein-protein interactions in cancer.
Mo X, Niu Q, Ivanov AA, Tsang YH, Tang C, Shu C, Li Q, Qian K, Wahafu A, Doyle SP, Cicka D, Yang X, Fan D, Reyna MA, Cooper LAD, Moreno CS, Zhou W, Owonikoko TK, Lonial S, Khuri FR, Du Y, Ramalingam SS, Mills GB, Fu H. Mo X, et al. Among authors: niu q. Cell. 2022 May 26;185(11):1974-1985.e12. doi: 10.1016/j.cell.2022.04.014. Epub 2022 May 4. Cell. 2022. PMID: 35512704 Free PMC article.
Autophagy-based unconventional secretion of HMGB1 in glioblastoma promotes chemosensitivity to temozolomide through macrophage M1-like polarization.
Li Z, Fu WJ, Chen XQ, Wang S, Deng RS, Tang XP, Yang KD, Niu Q, Zhou H, Li QR, Lin Y, Liang M, Li SS, Ping YF, Liu XD, Bian XW, Yao XH. Li Z, et al. Among authors: niu q. J Exp Clin Cancer Res. 2022 Feb 22;41(1):74. doi: 10.1186/s13046-022-02291-8. J Exp Clin Cancer Res. 2022. PMID: 35193644 Free PMC article.
Olverembatinib (HQP1351), a well-tolerated and effective tyrosine kinase inhibitor for patients with T315I-mutated chronic myeloid leukemia: results of an open-label, multicenter phase 1/2 trial.
Jiang Q, Li Z, Qin Y, Li W, Xu N, Liu B, Zhang Y, Meng L, Zhu H, Du X, Chen S, Liang Y, Hu Y, Liu X, Song Y, Men L, Chen Z, Niu Q, Wang H, Lu M, Yang D, Zhai Y, Huang X. Jiang Q, et al. Among authors: niu q. J Hematol Oncol. 2022 Aug 18;15(1):113. doi: 10.1186/s13045-022-01334-z. J Hematol Oncol. 2022. PMID: 35982483 Free PMC article. Clinical Trial.
1,607 results